Triregol coat. tabl.

Country: Belgium

Language: English

Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Buy It Now

Active ingredient:

Levonorgestrel 50 µg (pink tablet); Ethinylestradiol 30 µg (pink tablet); Levonorgestrel 75 µg (white tablet); Ethinylestradiol 40 µg (white tablet); Levonorgestrel 125 µg (ochre tablet); Ethinylestradiol 30 µg (ochre tablet)

Available from:

Gedeon Richter Plc

ATC code:

G03AB03

INN (International Name):

Ethinylestradiol; Levonorgestrel; Levonorgestrel; Ethinylestradiol; Levonorgestrel; Ethinylestradiol

Pharmaceutical form:

Coated tablet

Composition:

Ethinylestradiol 30 µg; Levonorgestrel 50 µg; Levonorgestrel 75 µg; Ethinylestradiol 40 µg; Levonorgestrel 125 µg; Ethinylestradiol 30 µg

Administration route:

Oral use

Therapeutic area:

Levonorgestrel and Ethinylestradiol

Product summary:

CTI code: 333566-03 - Pack size: 6 x 21 (6 + 5 + 10) - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 333566-04 - Pack size: 13 x 21 (10 + 6 + 5) - Commercialisation status: NO - FMD code: 05997001365946 - CNK code: 2678787 - Delivery mode: Medical prescription; CTI code: 333566-01 - Pack size: 21 (6 + 5 + 10) - Commercialisation status: NO - CNK code: 2678811 - Delivery mode: Medical prescription; CTI code: 333566-02 - Pack size: 3 x 21 (10 + 6 + 5) - Commercialisation status: NO - FMD code: 05997001365939 - CNK code: 2678803 - Delivery mode: Medical prescription

Authorization status:

Commercialised: No

Authorization date:

2009-02-17

Documents in other languages

Patient Information leaflet Patient Information leaflet German 01-07-2022
Patient Information leaflet Patient Information leaflet French 01-07-2022
DHPC DHPC French 20-09-2022
Patient Information leaflet Patient Information leaflet Dutch 01-07-2022
DHPC DHPC Dutch 20-09-2022